Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07803458 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Attention-based Binocular Training for Impaired Stereopsis (BRAVE)

Study acronym: BRAVE
StatusNot Yet Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Minor Study First Submitted
This study evaluates a novel attention-based binocular visual search training paradigm designed to improve stereopsis (stereo vision) in individuals with impaired binocular vision. Disruptions in balanced binocular input, such as from strabismus or anisometropia, often lead to deficient stereo vision, causing daily visuomotor limitations. While traditional therapies focus on monocular acuity, they frequently fail to restore stereopsis, especially in adults. The investigators propose a unique dichoptic visual search training method that embeds binocular disparity inside an attention-demanding task, encouraging cooperative binocular integration. Participants aged 18-39 with impaired stereopsis will be randomly assigned in a 1:1 ratio to either the active training group (disparity-embeded task) or the active control group (identical task with zero disparity). Both groups complete 5 training sessions over 5-6 weeks. Assessments will occur at baseline, immediately post-training, and at a 12-week follow-up. The primary objective is to determine if the active training group shows significantly greater improvements in local stereoacuity compared to the control group.
Trial Details
NCT Number NCT07803458
Lead Sponsor Centre for Eye and Vision Research
Collaborators: The Hong Kong Polytechnic University, University of Waterloo
Conditions
(from sponsor)
Amblyopia, Strabismus, Anisometropia, Binocular Vision Abnormalities, Binocular Vision Disorder
Related terms Amblyopia, Anisometropia, Strabismus
Enrollment 56 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov